IAI SPECIAL EDITION: Theobroma cacao L. (Cocoa) pod husk as a new therapy for transient receptor protein vanilloid-1 (TRPV1)-targeted diabetic neuropathy: An in silico study
DOI:
https://doi.org/10.46542/pe.2022.222.104108Keywords:
Cocoa pod husk, Painful diabetes neuropathy, Total phenol compound, TRPV1Abstract
Backgrounds: Theobroma cacao L. (cocoa) is one of the leading commodities found in Indonesia. Cocoa pod husk has many bioactive compounds with antinociceptive properties. One of the targets in treating pain, especially painful diabetic neuropathy, is the transient receptor potential vanilloid-1 (TRPV1).
Aim: This study aimed to investigate the activity of active compounds from cocoa pod husk extracts against TRPV1 and their toxicity.
Methods: Molecular docking was used to predict the activity of the test ligands, and the results were analysed with Molegro Virtual Docker 6.0. The TRPV 1 structure was taken from the Protein Data Bank (ID: 5IS0), with capsazepine as a native ligand. The toxicity prediction was evaluated using pkCSM.
Results: The results showed that the active chemical compounds from cocoa pod husks with the strongest affinity for TRPV1 were phlorofucofuroeckol-A (-95.7785 ± 1.868), catechins (-92.6868 ± 2.681), 7-phloroeckol (-91.9788 ± 0.356), and resveratrol (-91.1921 ± 0.579), and the safest compounds were catechins, resveratrol, and 7-phloroeckol.
Conclusion: Catechins, resveratrol, and 7-phloroeckol from cacao pod husks are safe and potential therapy for diabetic neuropathy.
References
Alleman, C.J.M., Westerhout, K.Y., Hensen, M., Chambers, C., Stoker, M., Long, S., et al. (2015). Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature. Diabetes Research and Clinical Practice. 109(2), 215–25. http://dx.doi.org/10.1016/j.diabres.2015.04.03
Bennet, L.Z., Hosey, C.M., Orsu, O., Oprea, T.I. (2016). BDDCS, the rule of 5 and drug ability. Advanced drug delivery reviews, 101, 89–98. https://doi.org/10.1016/j.addr.2016.05.007
Brito, R., Sheth, S., Mukherjea, D., Rybak, L.P., & Ramkumar, V. (2014). TRPV1: A Potential Drug Target for Treating Various Diseases. Cells, 3(2), 517–545. https://doi.org/10.3390/cells3020517
Cadiz-Gurrea, M.D.L.L., Fernández-Ochoa, Á., Leyva-Jiménez, F.J., Guerrero-Muñoz, N., Del Carmen Villegas-Aguilar, M., Pimentel-Moral S., et al. (2020). LC-MS and spectrophotometric approaches for evaluation of bioactive compounds from Peru cocoa by-products for commercial applications. Molecules. 25(14), 3177. https://doi.org/10.3390/molecules25143177
Carrasco, C., Naziroǧlu, M., Rodríguez, A.B., & Pariente, J.A. (2018). Neuropathic Pain: Delving into the Oxidative Origin and the Possible Implication of Transient Receptor Potential Channels. Frontiers in physiology, 9, 95. https://doi.org/10.3389/fphys.2018.00095
Fajrin, F.A., Nurrochmad, A., Nugroho, A.E., Susilowati, R. (2018). Molecular Docking Analysis of Ginger Active Compound on Transient Receptor Potential Cation Channel Subfamily V Member 1 (TRPV1). Indonesian Journal of Chemistry. 18(1), 179-185. https://doi.org/10.22146/ijc.28172
Farmer, K. L., Li, C., Dobrowsky, R.T. (2012). Diabetic Peripheral Neuropathy: Should a Chaperone Accompany Our Therapeutic Approach? Pharmacological Reviews, 64, 880–900. https://doi.org/10.1124/pr.111.005314
Karim, A.A., Azlan, A., Ismail, A., Hashim, P., Gani, S.S.A., Zainudin, B.H., et al. (2014). Phenolic composition, antioxidant, anti-wrinkles and tyrosinase inhibitory activities of cocoa pod extract. BMC complementary and alternative medicine. 14(1),1–13. https://doi.org/10.1186/1472-6882-14-381
Luongo, L., Costa, B., D’Agostino, B., Guida, F., Comelli, F., Gatta, L., et al. (2012). Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature. Pharmacology Research, 66(3), 243–250. https://doi.org/10.1016/j.phrs.2012.05.005
Morera, E., De Petrocellis, L., Morera, L., Schiano Moriello, A., Nalli, M., Di Marzo, V., et al. (2012). Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators. Bioorganic & Medicinal Chemistry Letters, 22(4), 1674–1677. https://doi.org/10.1016/j.bmcl.2011.12.113
Mustofa, F.I., Rahmawati, N., Saryanto. (2021). Ethnomedicine of medicinal plants used by traditional healers to facilitate bone injury healing in west kalimantan, indonesia. Jurnal Tumbuhan Obat Indonesia. 14(1), 36-54
Olasope, T., Fadupin, G., Olubamiwa, O., Jayeola, C. (2016). Glucose-lowering Potential of Cocoa Powder Intake - An Avenue for Positive Management of Diabetes Mellitus. British Journal of Medicine and Medical Research. 16(2):1–7. https://doi.org/10.9734/BJMMR/2016/24534
Pabbidi, R.M., Yu, S.-Q., Peng, S., Khardori, R., Pauza, M.E., Premkumar, L.S. (2008). Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity. Molecular Pain, 4: 9. https://doi.org/10.1186/1744-8069-4-9
Palazzo, E., Luongo, L., de Novellis, V., Berrino, L., Rossi, F., & Maione, S. (2010). Moving towards supraspinal TRPV1 receptors for chronic pain relief. Molecular pain, 6, 66. https://doi.org/10.1186/1744-8069-6-66
Panggalih, W.R., Pratoko, D.K., Fajrin, F.A. (2019). Molecular Docking Analysis and Toxicity Prediction of Curcumin Derivatives Against the Transient Receptor Potential Vanilloid 1 ( TRPV1 ) in Painful Diabetic Neuropathy. Jurnal Ilmu Dasar, 21(2), 133-138. https://doi.org/10.19184/jid.v21i2.15501
Urbanska, B., Kowalska, J. (2019). Comparison of the Total Polyphenol Content and Antioxidant Activity of Chocolate Obtained from Roasted and Unroasted Cocoa Beans from Different Regions of the World. Antioxidants. 8(8), 283. https://doi.org/10.3390/antiox8080283
WHO. (2017). Guidance document on evaluating and expressing uncertainty in hazard characterisation. 2nd Edition
WHO. (2019). The WHO Recommended Classi¬fication of Pesticides by Hazard and Guidelines to Classification
Zhuo, M. (2013). Long-term potentiation in the anterior cingulate cortex and chronic pain. Philosophical Transactions of the Royal Society B, 369(1633): 20130146. https://doi.org/10.1098/rstb.2013.0146
